AU Patent

AU2016315877B2 — Solid soluble ferric pyrophosphate formulations, kits, and methods using the same

Assigned to Rockwell Medical Inc · Expires 2022-05-26 · 4y expired

What this patent protects

A solid particulate formulation comprising soluble ferric pyrophosphate and a sachet comprising the solid particulate formulation of soluble ferric pyrophosphate for adding to a dialysis solution are provided. Improved methods of administering soluble ferric pyrophosphate compris…

USPTO Abstract

A solid particulate formulation comprising soluble ferric pyrophosphate and a sachet comprising the solid particulate formulation of soluble ferric pyrophosphate for adding to a dialysis solution are provided. Improved methods of administering soluble ferric pyrophosphate comprising the solid particulate formulations and kits comprising the solid particulate formulation and a dialysis concentrate formulation are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016315877B2
Jurisdiction
AU
Classification
—
Expires
2022-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Rockwell Medical Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.